Identifying and treating clinical subgroups of patients with epilepsy: a case review (Q35156938)

6 August 2017

1 reference

title

Identifying and treating clinical subgroups of patients with epilepsy: a case review (English)

1 reference

6 August 2017

Gregory L Krauss

1

1 reference

6 August 2017

Eva K Ritzl

series ordinal

2

1 reference

6 August 2017

publication date

1 May 2003

1 reference

Medical Clinics of North America

6 August 2017

published in

1 reference

6 August 2017

volume

87

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

725-46, viii

1 reference

Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

The role of clinical neurophysiology in the management of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Effectiveness of multiple EEGs in supporting the diagnosis of epilepsy: an operational curve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Seizure recurrence after a 1st unprovoked seizure: an extended follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Risk of Recurrent Seizures after Two Unprovoked Seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Epilepsy emergencies: the first seizure and status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

The challenge of treatment selection for epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Medical management of epilepsy in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Effectiveness of first antiepileptic drug.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Treatment of seizures and epilepsy in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Valproic acid versus ethosuximide in the treatment of absence seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Optimizing health outcomes in active epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Efficacy, pharmacology, and adverse effects of antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

7 January 2021

Safety of lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Hyponatraemia during oxcarbazepine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Anticonvulsant teratogenesis: I. A study design for newborn infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Disposition of carbamazepine and phenytoin in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Epilepsy in elderly people

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Epilepsy in the elderly: some clinical and pharmacotherapeutic aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Meeting the Challenge of Epilepsy in Persons With Multiple Handicaps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Significant anticonvulsant side-effects in children and adolescents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Long-term prognosis of seizures with onset in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Vagus nerve stimulation and the ketogenic diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Vagus nerve stimulation: clinical experience in a large patient series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

7 January 2021

Vagus nerve stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

A randomized, controlled trial of surgery for temporal-lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Seizure control and mortality in epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Long-term seizure outcome and antiepileptic drug treatment in surgically treated temporal lobe epilepsy patients: a controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Surgery for temporal lobe epilepsy in older patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Early identification of refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Seizure outcome after surgery for epilepsy due to malformation of cortical development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Medically intractable, localization-related epilepsy with normal MRI: presurgical evaluation and surgical outcome in 43 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

An estimate of the prevalence of psychogenic non-epileptic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

When drugs don't work: an algorithmic approach to medically intractable epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

Marketed new antiepileptic drugs: are they better than old-generation agents?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900010-5

10.1016/S0025-7125(03)00010-5

7 January 2021

Identifiers

DOI

1 reference

release_sgxhvsblwnazrdmvweeopk6lry

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sgxhvsblwnazrdmvweeopk6lry

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference